Skip to Main Content

Paper Details

Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.
J Natl Compr Canc Netw
5
2019
ERBB2, ERBB2 mRNA, RNA, Trastuzumab, UC, Urothelial Cancer, Urothelial carcinoma, cancer, patient, patients, platinum, trastuzumab, tumors, whole
Author NameAffiliation
Rohan Bareja
Rohan BarejaInstitute for Computational Biomedicine
Brian D Robinson
Brian D RobinsonEnglander Institute for Precision Medicine.
Juan Miguel Mosquera
Juan Miguel MosqueraEnglander Institute for Precision Medicine.
Juan Miguel Mosquera
Juan Miguel MosqueraEnglander Institute for Precision Medicine.
Douglas S Scherr
Andrea Sboner
Andrea SbonerEnglander Institute for Precision Medicine.
Andrea SbonerInstitute for Computational Biomedicine
Andrea Sboner
Andrea SbonerInstitute for Computational Biomedicine
Andrea SbonerEnglander Institute for Precision Medicine.
Scott T Tagawa
Scott T TagawaEnglander Institute for Precision Medicine.
Scott T Tagawa
Scott T TagawaSandra and Edward Meyer Cancer Center
Ana M Molina
Ana M MolinaEnglander Institute for Precision Medicine.
Ana M Molina
Ana M MolinaSandra and Edward Meyer Cancer Center
Olivier Elemento
Olivier ElementoSandra and Edward Meyer Cancer Center
Olivier ElementoEnglander Institute for Precision Medicine.
Olivier ElementoInstitute for Computational Biomedicine
Olivier Elemento
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoEnglander Institute for Precision Medicine.
Olivier ElementoSandra and Edward Meyer Cancer Center
David M Nanus
David M NanusEnglander Institute for Precision Medicine.
David M Nanus
David M NanusSandra and Edward Meyer Cancer Center
Bishoy M Faltas
Bishoy M FaltasEnglander Institute for Precision Medicine.
Bishoy M FaltasSandra and Edward Meyer Cancer Center
  • 1 - 38

Datasets

Release 1.2